| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |